Watertown’s Lyndra strikes Alzheimer’s pact with Allergan worth up to $105M By: Boston Business Journal via Business Journals September 07, 2017 at 07:01 AM EDT Under the deal, the companies will seek to use Lyndra's technology to develop once-weekly formulations of Allergan’s drugs. Read More >> Related Stocks: Mint Corp
